imazodan has been researched along with Carcinoma, Epidermoid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dhar, S; Fryknäs, M; Gullbo, J; Gustafsson, MG; Isaksson, A; Larsson, R; Lövborg, H; Nygren, P; Rickardson, L; Wickström, M | 1 |
1 other study(ies) available for imazodan and Carcinoma, Epidermoid
Article | Year |
---|---|
Phenotype-based screening of mechanistically annotated compounds in combination with gene expression and pathway analysis identifies candidate drug targets in a human squamous carcinoma cell model.
Topics: Carcinoma, Squamous Cell; Caspases; Combinatorial Chemistry Techniques; Drug Evaluation, Preclinical; Electronic Data Processing; Gene Expression Profiling; HeLa Cells; Humans; Models, Biological; Oligonucleotide Array Sequence Analysis; Phenotype; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyridazines; Quinazolines; RNA, Messenger; Signal Transduction | 2006 |